Barinthus Biotherapeutics plc (BRNS) Tops Q1 EPS by 18c

Barinthus Biotherapeutics plc (NASDAQ: BRNS) reported Q1 EPS of ($0.14), $0.18 better than the analyst estimate of ($0.32).

For earnings history and earnings-related data on Barinthus Biotherapeutics plc (BRNS) click here.

You May Also Be Interested In

• UBS Assumes Interactive Brokers Group (IBKR) at Neutral, 'A Best-in-Class, Yet Fairly Valued Brokerage'
• Science Applications (SAIC) PT Raised to $154 at Stifel
• Sphere Entertainment (SPHR) Reiterated at Market Outperform by Citizens: Global Expansion Apace